Goldman Sachs’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-402,502
| Closed | -$1.25M | – | 7217 |
|
|
2021
Q4 | $1.25M | Sell |
402,502
-145,340
| -27% | -$489K | ﹤0.01% | 4651 |
|
|
2021
Q3 | $1.98M | Sell |
547,842
-1,412,164
| -72% | -$5.33M | ﹤0.01% | 4210 |
|
|
2021
Q2 | $7.02M | Sell |
1,960,006
-832,700
| -30% | -$2.94M | ﹤0.01% | 3034 |
|
|
2021
Q1 | $10.9M | Buy |
2,792,706
+1,080,270
| +63% | +$4.46M | ﹤0.01% | 2485 |
|
|
2020
Q4 | $7.19M | Buy |
1,712,436
+539,544
| +46% | +$2.08M | ﹤0.01% | 2711 |
|
|
2020
Q3 | $4.38M | Buy |
1,172,892
+141,185
| +14% | +$601K | ﹤0.01% | 3008 |
|
|
2020
Q2 | $4.5M | Buy |
1,031,707
+60,087
| +6% | +$270K | ﹤0.01% | 2869 |
|
|
2020
Q1 | $3.68M | Buy |
971,620
+32,394
| +3% | +$159K | ﹤0.01% | 2874 |
|
|
2019
Q4 | $5.94M | Buy |
939,226
+431,858
| +85% | +$2.54M | ﹤0.01% | 2818 |
|
|
2019
Q3 | $2.14M | Buy |
507,368
+474,186
| +1,429% | +$2.03M | ﹤0.01% | 3484 |
|
|
2019
Q2 | $155K | Sell |
33,182
-635,718
| -95% | -$2.96M | ﹤0.01% | 4858 |
|
|
2019
Q1 | $3.54M | Buy |
668,900
+654,550
| +4,561% | +$2.99M | ﹤0.01% | 3234 |
|
|
2018
Q4 | $53K | Sell |
14,350
-506
| -3% | -$1.78K | ﹤0.01% | 5087 |
|
|
2018
Q3 | $42K | Sell |
14,856
-15,084
| -50% | -$42.3K | ﹤0.01% | 5323 |
|
|
2018
Q2 | $88K | Sell |
29,940
-29,494
| -50% | -$69.9K | ﹤0.01% | 5244 |
|
|
2018
Q1 | $134K | Sell |
59,434
-16,159
| -21% | -$37.8K | ﹤0.01% | 5170 |
|
|
2017
Q4 | $223K | Buy |
+75,593
| New | +$209K | ﹤0.01% | 5366 |
|
|
2017
Q2 | – | Sell |
-30,243
| Closed | -$57K | – | 7205 |
|
|
2017
Q1 | $57K | Sell |
30,243
-50,301
| -62% | -$97K | ﹤0.01% | 6256 |
|
|
2016
Q4 | $141K | Sell |
80,544
-57,975
| -42% | -$118K | ﹤0.01% | 5973 |
|
|
2016
Q3 | $374K | Sell |
138,519
-49,663
| -26% | -$126K | ﹤0.01% | 5307 |
|
|
2016
Q2 | $444K | Buy |
188,182
+85,090
| +83% | +$235K | ﹤0.01% | 4955 |
|
|
2016
Q1 | $333K | Sell |
103,092
-25,737
| -20% | -$95.1K | ﹤0.01% | 5166 |
|
|
2015
Q4 | $617K | Sell |
128,829
-327,728
| -72% | -$1.86M | ﹤0.01% | 4737 |
|
|
2015
Q3 | $2.54M | Sell |
456,557
-78,308
| -15% | -$578K | ﹤0.01% | 3558 |
|
|
2015
Q2 | $4.26M | Buy |
534,865
+511,076
| +2,148% | +$4.39M | ﹤0.01% | 3105 |
|
|
2015
Q1 | $250K | Sell |
23,789
-12,439
| -34% | -$170K | ﹤0.01% | 5823 |
|
|
2014
Q4 | $435K | Buy |
36,228
+6,504
| +22% | +$98.8K | ﹤0.01% | 5425 |
|
|
2014
Q3 | $508K | Buy |
+29,724
| New | +$431K | ﹤0.01% | 5249 |
|
|
2014
Q2 | – | Sell |
-35,615
| Closed | -$301K | – | 7364 |
|
|
2014
Q1 | $301K | Buy |
+35,615
| New | +$287K | ﹤0.01% | 5737 |
|
Other funds holding BDSI
Goldman Sachs's BDSI Position: Q1 2022 in Review
Goldman Sachs sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 402,502 shares — an estimated $1.25M sold.
Goldman Sachs first reported a position in BDSI in Q1 2014 and held it in 29 quarters. The position peaked at $10.9M in Q1 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Goldman Sachs reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Goldman Sachs sold 402,502 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1.25M.
- Goldman Sachs first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 29 quarters.
- Goldman Sachs's BioDelivery Sciences International, Inc. position peaked at $10.9M in Q1 2021.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.